Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros

Medicinas Complementárias
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Int Immunopharmacol ; 74: 105681, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31220694

RESUMEN

Salmonella typhimurium (S. t.) is one of the main pathogens that causes acute gastroenteritis. To evaluate the anti-inflammatory mechanism of Astragalus polysaccharide (APS) in vivo and its influence on the intestinal flora, BALB/c mice were infected with S. t. to establish a model of diarrhea. The disease activity index (DAI) scores showed that APS attenuated S. t.-induced weight loss and diarrhea in mice. APS significantly reduced the index of the liver and spleen as well as the ALT and AST levels in serum (P < 0.05). Hematoxylin and eosin (H&E) results indicated that APS significantly increased jejunum villus height and crypt depth and reduced the infiltration of inflammatory cells (P < 0.05). Additionally, APS increased the tight junction (TJ) proteins expression levels of ZO-1, Occludin and Claudin-1 in the jejunum. The results of 16S rDNA showed that APS significantly increased the number of Lactobacillus and Bifidobacterium spp. to normal levels (compared with the control group). In addition, APS significantly decreased the mRNA expression levels of the proinflammatory cytokines TNF-α, IL-1ß, IL-6 and IL-17 in the jejunum (P < 0.01) as well as the proteins expression levels of COX-2 and iNOS (P < 0.05). Western blot confirmed that prefeeding with APS inhibited S. t.-induced expression of TLR4 and MyD88 in the jejunum and further inhibited nuclear factor-κB (NF-κB) activation, including the nuclear translocation of the p65 NF-κB subunit and the phosphorylation and degradation of IκB-α. This was the key to APS inhibition of the production of inflammatory factors and inflammatory mediators in the jejunum.


Asunto(s)
Antiinflamatorios/uso terapéutico , Bifidobacterium/genética , Diarrea/terapia , Microbioma Gastrointestinal/genética , Lactobacillus/genética , Hígado/metabolismo , Polisacáridos/uso terapéutico , Infecciones por Salmonella/terapia , Salmonella typhimurium/fisiología , Uniones Estrechas/metabolismo , Animales , Planta del Astrágalo/inmunología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Humanos , Mediadores de Inflamación/metabolismo , Hígado/patología , Ratones , Ratones Endogámicos BALB C , FN-kappa B/metabolismo , Transducción de Señal , Uniones Estrechas/patología
2.
J Immunol Res ; 2017: 1787803, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29318160

RESUMEN

The present study was aimed at determining the activity of aqueous and methanolic extracts of Tinospora cordifolia (AETC and METC) against Salmonella typhimurium. In vitro anti-Salmonella activity of T. cordifolia was determined through the broth dilution and agar well diffusion assays. The immune-stimulating potential of AETC or METC was determined by measuring the cytokine levels in the culture supernatants of treated murine J774 macrophages. Antibacterial activity of AETC or METC was determined by treating S. typhimurium-infected macrophages and BALB/C mice. The toxicity of AETC or METC was determined by measuring the levels of liver inflammation markers aspartate transaminase (AST) and alanine transaminase (ALT) and antioxidant enzymes. Macrophages treated with AETC or METC secreted greater levels of IFN-γ, TNF-α, and IL-1ß. METC showed greater activity against S. typhimurium infection in macrophages and mice as well. Treatment with METC resulted in increased survival and reduced bacterial load in S. typhimurium-infected mice. Moreover, METC or AETC treatment reduced the liver inflammation and rescued the levels of antioxidant enzymes in S. typhimurium-infected mice. The results of the present study suggest that the use of T. cordifolia may act as a double-edged sword in combating salmonellosis.


Asunto(s)
Hepatitis A/terapia , Macrófagos/efectos de los fármacos , Extractos Vegetales/uso terapéutico , Salmonelosis Animal/terapia , Infecciones por Salmonella/terapia , Salmonella typhimurium/fisiología , Alanina Transaminasa/sangre , Animales , Aspartato Aminotransferasas/sangre , Carga Bacteriana/efectos de los fármacos , Línea Celular , Citocinas/metabolismo , Hepatitis A/inmunología , Humanos , Inmunomodulación , Mediadores de Inflamación/metabolismo , Macrófagos/inmunología , Macrófagos/microbiología , Metanol/química , Ratones , Ratones Endogámicos BALB C , Infecciones por Salmonella/inmunología , Salmonelosis Animal/inmunología , Salmonella typhimurium/efectos de los fármacos , Tinospora/inmunología , Agua/química
3.
Pan Afr Med J ; 22: 357, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26985275

RESUMEN

A case of rarely encountered nontyphoidal Salmonella septic arthritis of the elbow in an infant with no preexisting disease is reported. Salmonella etiology was not suspected in this case, and the diagnosis was made only after bacterial isolation. Aspiration of the infected joint with radiological guidance initially failed to give a good clinical response. Arthrotomy was done with intravenous cefotaxime for 4 weeks followed by 2 weeks oral ciprofloxacin therapy to which the child responded favorably. Up to our knowledge this is the first case of nontyphoidal salmonella elbow septic arthritis in an infant in Saudi Arabia to be reported in the English literature.


Asunto(s)
Antibacterianos/uso terapéutico , Artritis Infecciosa/diagnóstico , Articulación del Codo/patología , Infecciones por Salmonella/diagnóstico , Antibacterianos/administración & dosificación , Artritis Infecciosa/microbiología , Artritis Infecciosa/terapia , Cefotaxima/administración & dosificación , Cefotaxima/uso terapéutico , Ciprofloxacina/administración & dosificación , Ciprofloxacina/uso terapéutico , Articulación del Codo/microbiología , Femenino , Humanos , Lactante , Infecciones por Salmonella/microbiología , Infecciones por Salmonella/terapia , Arabia Saudita , Resultado del Tratamiento
4.
Analyst ; 139(15): 3702-5, 2014 Aug 07.
Artículo en Inglés | MEDLINE | ID: mdl-24897935

RESUMEN

Monoclonal antibody-conjugated sphere-shaped gold nanoparticles were combined with single-walled carbon nanotubes (SWCNTs) to create a nanohybrid system to selectively detect and eradicate multiple drug resistant Salmonella (MDRS) typhimurium DT104 bacteria. The Raman signal intensity from Rhodamine 6G (Rh6G) modified monoclonal AC04 antibody SWCNTs-gold nanoparticle (SWCNT-GNPs) hybrid provided a SERS enhancement by several orders of magnitude to detect the MDRS bacteria over the GNP system. A targeted photothermolysis experiment using 670 nm light at 2 W cm(-2) for 15 min, resulted in selective and irreparable damage to more than 99% Salmonella DT104 at the concentration of 10(5) CFU mL(-1). In comparison to solely SWCNTs or GNPs, our SWCNT-GNPs nanohybrids have also shown a better photothermal efficiency.


Asunto(s)
Oro/química , Nanopartículas del Metal/química , Nanotubos de Carbono/química , Rodaminas/administración & dosificación , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/aislamiento & purificación , Anticuerpos Monoclonales/inmunología , Oro/farmacología , Humanos , Nanopartículas del Metal/uso terapéutico , Fotólisis , Fototerapia , Rodaminas/uso terapéutico , Infecciones por Salmonella/microbiología , Infecciones por Salmonella/terapia , Salmonella typhimurium/inmunología , Salmonella typhimurium/efectos de la radiación , Espectrometría Raman
5.
J Med Food ; 12(3): 576-83, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19627206

RESUMEN

In the present study, effect of dahi containing probiotic Lactobacillus casei (probiotic dahi) was evaluated to modulate immune response against Salmonella enteritidis infection in mice. Animals were fed with milk products along with standard diet for 2 and 7 days prior to the S. enteritidis challenge and continued on the respective dairy food-supplemented diets during the postchallenge period. Translocation of S. enteritidis in spleen and liver, beta-galactosidase and beta-glucuronidase enzymatic activities and secretory IgA (sIgA) in intestinal fluid, lymphocyte proliferation, and cytokine (interleukin [IL]-2, IL-4, IL-6, and interferon-gamma [IFN-gamma]) production in cultured splenocytes were assessed on day 2, 5, and 8 of the postchallenge period. Colonization of S. enteritidis in liver and spleen was remarkably low in probiotic dahi-fed mice than mice fed milk and control dahi. The beta-galactosidase and beta-glucuronidase activities in intestinal fluid collected from mice prefed for 7 days with probiotic dahi were significantly lower at day 5 and 8 postchallenge than in mice fed milk and control dahi. Levels of sIgA and lymphocyte proliferation rate were also significantly increased in probiotic dahi-fed mice compared with the other groups. Production of IL-2, IL-6, and IFN-gamma increased, whereas IL-4 decreased in splenic lymphocytes collected from probiotic dahi-fed mice. Data showed that dahi prefed for 7 days before S. enteritidis challenge was more effective than when mice were prefed for 2 days with dahi. Moreover, probiotic dahi was more efficacious in protecting against S. enteritidis infection by enhancing innate and adaptive immunity than fermented milk and normal dahi. Results of the present study suggest that prefeeding of probiotic dahi may strengthen the consumer's immune system and may protect infectious agents like S. enteritidis.


Asunto(s)
Productos Lácteos Cultivados/microbiología , Factores Inmunológicos/uso terapéutico , Lacticaseibacillus casei , Probióticos/uso terapéutico , Infecciones por Salmonella/terapia , Salmonella enteritidis , Animales , Traslocación Bacteriana/fisiología , Búfalos , Proliferación Celular , Citocinas/biosíntesis , Fermentación , Glucuronidasa/metabolismo , Inmunoglobulina A Secretora/metabolismo , Hígado/microbiología , Linfocitos/metabolismo , Masculino , Ratones , Infecciones por Salmonella/inmunología , Infecciones por Salmonella/metabolismo , Salmonella enteritidis/fisiología , Bazo/inmunología , Bazo/microbiología , beta-Galactosidasa/metabolismo
6.
Microb Biotechnol ; 1(3): 247-57, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-21261844

RESUMEN

The increasing occurrence of antibiotic-resistant pathogens is of growing concern, and must be counteracted by alternative antimicrobial treatments. Bacteriophages represent the natural enemies of bacteria. However, the strong immune response following application of phages and rapid clearance from the blood stream are hurdles which need to be overcome. Towards our goal to render phages less immunogenic and prolong blood circulation time, we have chemically modified intact bacteriophages by conjugation of the non-immunogenic polymer monomethoxy-polyethylene glycol (mPEG) to virus proteins. As a proof of concept, we have used two different polyvalent and strictly virulent phages of the Myoviridae, representing typical candidates for therapeutical approaches: Felix-O1 (infects Salmonella) and A511 (infects Listeria). Loss of phage infectivity after PEGylation was found to be proportional to the degree of modification, and could be conveniently controlled by adjusting the PEG concentration. When injected into naïve mice, PEGylated phages showed a strong increase in circulation half-life, whereas challenge of immunized mice did not reveal a significant difference. Our results suggest that the prolonged half-life is due to decreased susceptibility to innate immunity as well as avoidance of cellular defence mechanisms. PEGylated viruses elicited significantly reduced levels of T-helper type 1-associated cytokine release (IFN-γ and IL-6), in both naïve and immunized mice. This is the first study demonstrating that PEGylation can increases survival of infective phage by delaying immune responses, and indicates that this approach can increase efficacy of bacteriophage therapy.


Asunto(s)
Terapia Biológica/métodos , Listeriosis/terapia , Myoviridae/química , Myoviridae/inmunología , Infecciones por Salmonella/terapia , Linfocitos T Colaboradores-Inductores/inmunología , Animales , Circulación Sanguínea , Modelos Animales de Enfermedad , Humanos , Listeria/fisiología , Listeria/virología , Listeriosis/inmunología , Listeriosis/microbiología , Masculino , Ratones , Ratones Endogámicos BALB C , Myoviridae/fisiología , Polietilenglicoles/química , Infecciones por Salmonella/inmunología , Infecciones por Salmonella/microbiología , Salmonella typhimurium/fisiología , Salmonella typhimurium/virología , Factores de Tiempo
9.
Lik Sprava ; (3): 140-2, 1999.
Artículo en Ruso | MEDLINE | ID: mdl-10474963

RESUMEN

The paper presents results of multiple-modality treatment of patients with acute intestinal infections with making use of the drug preparation Kaopectate incorporating activated attapulgite which is a natural mixture of hydrates of magnesium silicate and silicate of alumina. The above drug has been shown to be endowed with a antidiarrheal and detoxifying activities.


Asunto(s)
Antidiarreicos/uso terapéutico , Disentería Bacilar/terapia , Enfermedades Intestinales/terapia , Caolín/uso terapéutico , Pectinas/uso terapéutico , Infecciones por Salmonella/terapia , Shigella flexneri , Shigella sonnei , Adulto , Terapia Combinada , Combinación de Medicamentos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de Tiempo
10.
Br. homoeopath. j ; 87(3): 131-4, july 1998. tab
Artículo en Inglés | HomeoIndex | ID: hom-5870

RESUMEN

The aim of this research was to compare the effectiveness of Baptisia tinctoria 30c and Ciprofloxacin against salmonellosis in fowl. Eight hundred (400 first quality and 400 second quality) poultry birds were used. All were the same commercial brand. There were... (AU)


Asunto(s)
Estudio Comparativo , Animales , Infecciones por Salmonella/terapia , Baptisia tinctoria/uso terapéutico , Ciprofloxacina/uso terapéutico , Pollos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA